Last updated on December 2017

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Testicular Safety of Filgotinib in Adult Males with Moderately to Severely Active Ulcerative Colitis.


Brief description of study

This study is designed to evaluate the effect of treatment with filgotinib on testicular safety in adult males with moderately to severely active Ulcerative Colitis (UC).

Stipend range: $75o/v, $100proc

For those patients who complete the trial, they will be eligible for the long-term extension study, for up to 195 additional weeks. 

Clinical Study Identifier: TX154995

Contact Investigators or Research Sites near you

Start Over

MariCarmen Korngiebel-Rosique, MS, CRC

Gastroenterology Associates of Tidewater
Chesapeake, VA USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.